About OEPIntroduction

Founded in 1982, Orient Europharma Co., Ltd. was officially listed in the R.O.C Taiwan Stock Exchange GreTai Securities Market for trading in November 2003. Upholding the corporate core values of “integrity, solidarity, and creativity,” Orient Europharma is constantly committed to creating health and beauty, and it is also a multinational pharmaceutical company with marketing, sales, R&D, and manufacturing capabilities.

Since establishment, Orient Europharma has constantly introduced unique healthcare products. It also boasts representative products in the fields of general pharmaceutical, oncology, dermo-cosmetics, nutrition and baby care, and healthcare supplement, which are popular and highly recognized among the consumers. Meanwhile, operated by the professional marketing and sales team with dense channels, Orient Europharma has achieved continuous growth and profit creation. Now it has developed its own R&D and manufacturing capabilities and has engaged in new drug R&D and clinical trials with the collaborated efforts of many original foreign pharmaceutical companies in preparation for marketing the future drugs produced to other countries in Asia and the United States.

In the international development, Orient Europharma has set up seven subsidiaries overseas, including the United States, China, Hong Kong, Philippines, Singapore, and Malaysia. An office has also been set up in Vietnam to expand the local market. Additionally, OrientPharma, Orient Europharma’s important subsidiary through reinvestment was completed and opened in 2010. It has obtained the PIC/S GMP certification of the Food and Drug Administration, Department of Health, Executive Yuan, and mass production is expected to commence by 2012.

Of the top domestic 1,000 enterprises in the 2010 survey released by Commonwealth Magazine, Orient Europharma ranks 514th, placing it number four in the biotech category. Through strategic partnerships and customer resource integration, Orient Europharma will continue to develop brand products with potential, and provide consumers with advanced medical and healthcare drugs, continuously enhancing the medical quality in Asian regions.

History of OEP